Phase II study of 5-fluorouracil plus leucovorin and interferon alpha 2b in advanced colorectal cancer
- 31 May 1992
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 28 (4-5) , 850-852
- https://doi.org/10.1016/0959-8049(92)90130-t
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Phase II study of fluorouracil and recombinant interferon alfa-2a in previously untreated advanced colorectal carcinoma.Journal of Clinical Oncology, 1990
- Levamisole and Fluorouracil for Adjuvant Therapy of Resected Colon CarcinomaNew England Journal of Medicine, 1990
- Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. The North Central Cancer Treatment Group and the Mayo Clinic.Journal of Clinical Oncology, 1989
- Superiority of sequential methotrexate, fluorouracil, and leucovorin to fluorouracil alone in advanced symptomatic colorectal carcinoma: a randomized trial.Journal of Clinical Oncology, 1989
- Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma.Journal of Clinical Oncology, 1989
- A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma: a Mid-Atlantic Oncology Program Study.Journal of Clinical Oncology, 1989
- Overview of clinical trials using 5-fluorouracil and leucovorin for the treatment of colorectal cancerCancer, 1989
- Optimal two-stage designs for phase II clinical trialsControlled Clinical Trials, 1989